NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
03.04.02 Allergen Immunotherapy
03.04.02 Omalizumab

Omalizumab 150mg, 300mg (Xolair®)
(Pre-Filled Syringe, Injection )

RED
Restricted Drug Restricted

FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.

Restricted to prescribing by NICE criteria or by approved individual funding request (IFR) ONLY.

1. Restricted - prescribing by Consultant Respiratory Physicians and Consultant Paediatricians in accordance with NICE TA 278 Omalizumab for treating severe persistent allergic asthma.

2. Restricted - prescribing by Consultant Dermatologists in accordance with NICE TA339 for previously treated chronic spontaneous urticaria.

Classifications
May be initiated in any care setting
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.